AIM Vaccine Co., Ltd. (HKG:6660)
Hong Kong · Delayed Price · Currency is HKD 2.670
-0.210 (-7.29%)
Apr 17, 2026, 4:08 PM HKT
AIM Vaccine Market Cap
AIM Vaccine has a market cap or net worth of 3.53 billion as of April 17, 2026. Its market cap has decreased by -28.89% in one year.
Market Cap
3.53B
Enterprise Value
5.29B
Revenue
1.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
2.67
Market Cap Chart
Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 3.53B, a decrease of -82.47%. That is a compound annual growth rate of -38.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 3.53B | -10.28% |
| Dec 31, 2025 | 3.94B | -47.05% |
| Dec 31, 2024 | 7.44B | -21.78% |
| Dec 29, 2023 | 9.51B | -67.02% |
| Dec 30, 2022 | 28.82B | 43.02% |
| Oct 6, 2022 | 20.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qyuns Therapeutics | 4.71B |
| Shandong Boan Biotechnology | 4.53B |
| Beijing Luzhu Biotechnology | 4.36B |
| TYK Medicines | 4.24B |
| Antengene Corporation | 4.18B |
| Viva Biotech Holdings | 4.05B |
| Clover Biopharmaceuticals | 3.79B |
| BioDlink International Company | 3.78B |